XTANT MEDICAL HOLDINGS, INC. (XTNT) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 29.96M USD | Liabilities, Current |
| Cash and equivalents | 9.87M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 19.42M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 33.29M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $29.96M | $9.87M | (m) | $19.42M | $33.29M | (m) |
| 2026-03-31 | (m) | $18.77M | $12.14M | (m) | $17.18M | $31.88M | (m) |
| 2025-12-31 | (m) | $29.48M | $17.05M | (m) | $17.80M | $30.26M | (m) |
| 2025-09-30 | (m) | $35.50M | $10.40M | (m) | $25.52M | $40.71M | (m) |
| 2025-06-30 | (m) | $30.60M | $6.92M | (m) | $26.95M | $40.13M | (m) |
| 2025-03-31 | (m) | $29.58M | $5.03M | (m) | $23.48M | $38.81M | (m) |
| 2024-12-31 | (m) | $28.58M | $6.20M | (m) | $20.66M | $38.63M | (m) |
| 2024-09-30 | (m) | $33.67M | $6.60M | (m) | $20.55M | $41.89M | (m) |
| 2024-06-30 | (m) | $28.31M | $5.38M | (m) | $21.19M | $40.51M | (m) |
| 2024-03-31 | (m) | $28.44M | $4.55M | (m) | $21.48M | $38.72M | (m) |
| 2023-12-31 | (m) | $22.99M | $5.71M | (m) | $20.73M | $36.88M | (m) |
| 2023-09-30 | (m) | $21.92M | $8.66M | (m) | $19.15M | $34.33M | (m) |
| 2023-06-30 | (m) | $16.99M | $4.14M | (m) | $13.74M | $20.36M | (m) |
| 2023-03-31 | (m) | $17.28M | $5.18M | (m) | $11.90M | $18.52M | (m) |
| 2022-12-31 | (m) | $15.22M | $20.30M | (m) | $10.85M | $17.29M | (m) |
| 2022-09-30 | (m) | $11.36M | $17.36M | (m) | $9.84M | $16.99M | (m) |
| 2022-06-30 | (m) | $11.86M | $16.50M | (m) | $8.60M | $16.46M | (m) |
| 2022-03-31 | (m) | $11.23M | $16.85M | (m) | $7.54M | $17.30M | (m) |
| 2021-12-31 | (m) | $11.08M | $18.24M | (m) | $7.15M | $17.95M | (m) |
| 2021-09-30 | (m) | $10.40M | $18.18M | (m) | $6.32M | $19.71M | (m) |
| 2021-06-30 | (m) | $12.91M | $20.31M | (m) | $6.99M | $21.09M | (m) |
| 2021-03-31 | (m) | $24.01M | $18.64M | (m) | $7.03M | $21.64M | (m) |
| 2020-12-31 | (m) | $25.65M | $2.34M | (m) | $6.88M | $21.41M | (m) |
| 2020-09-30 | (m) | $9.33M | $2.74M | (m) | $7.32M | $20.67M | (m) |
| 2020-06-30 | (m) | $9.47M | $3.02M | (m) | $7.58M | $19.89M | (m) |
| 2020-03-31 | (m) | $10.06M | $3.24M | (m) | $9.74M | $18.04M | (m) |
| 2019-12-31 | (m) | $9.39M | $5.24M | (m) | $10.12M | $16.10M | (m) |
| 2019-09-30 | (m) | $9.08M | $5.75M | (m) | $9.12M | $16.02M | (m) |
| 2019-06-30 | (m) | $9.93M | $7.32M | (m) | $8.56M | $15.83M | (m) |
| 2019-03-31 | (m) | $11.25M | $7.10M | (m) | $9.49M | $16.53M | (m) |
| 2018-12-31 | (m) | $12.05M | $6.80M | (m) | $9.99M | $17.30M | (m) |
| 2018-09-30 | (m) | $10.42M | $5.06M | (m) | $9.87M | $22.19M | (m) |
| 2018-06-30 | (m) | $12.39M | $6.05M | (m) | $10.40M | $22.45M | (m) |
| 2018-03-31 | (m) | $11.99M | $6.17M | (m) | $10.34M | $22.51M | (m) |
| 2017-12-31 | (m) | $25.82M | $2.86M | (m) | $12.71M | $22.23M | (m) |
| 2017-09-30 | (m) | $87.25M | $2.07M | (m) | $13.91M | $24.04M | (m) |
| 2017-06-30 | (m) | $20.85M | $1.66M | (m) | $15.85M | $24.93M | (m) |
| 2017-03-31 | (m) | $28.90M | $2.49M | (m) | $16.32M | $26.36M | (m) |
| 2016-12-31 | (m) | $31.12M | $2.58M | (m) | $18.99M | $26.27M | (m) |
| 2016-09-30 | (m) | $28.47M | $1.41M | (m) | $15.83M | $26.50M | (m) |
| 2016-06-30 | (m) | $25.60M | $2.22M | (m) | $14.72M | $25.51M | (m) |
| 2016-03-31 | (m) | $25.58M | $4.67M | (m) | $14.92M | $24.20M | (m) |
| 2015-12-31 | (m) | $21.47M | $6.37M | (m) | $15.39M | $22.68M | (m) |
| 2015-09-30 | (m) | $16.74M | $7.97M | (m) | $13.32M | $22.04M | (m) |
| 2015-06-30 | (m) | $10.33M | $2.03M | (m) | $5.57M | $9.39M | (m) |
| 2015-03-31 | (m) | $10.36M | $2.90M | (m) | $5.50M | $9.71M | (m) |
| 2014-12-31 | (m) | $8.48M | $4.47M | (m) | $4.43M | $9.56M | (m) |
| 2014-09-30 | (m) | $9.38M | $6.95M | (m) | $4.29M | $11.14M | (m) |
| 2014-06-30 | (m) | $9.81M | $2.99M | (m) | $4.90M | $10.52M | (m) |
| 2014-03-31 | (m) | $11.55M | $4.77M | (m) | $5.53M | $10.50M | (m) |
| 2013-12-31 | (m) | $9.65M | $3.05M | (m) | $4.79M | $10.75M | (m) |
| 2013-09-30 | (m) | $8.85M | $3.44M | (m) | $4.63M | $13.23M | (m) |
| 2013-06-30 | (m) | $9.50M | $5.14M | (m) | $6.23M | $13.80M | (m) |
| 2013-03-31 | (m) | $8.44M | $2.12M | (m) | $7.16M | $13.61M | (m) |
| 2012-12-31 | (m) | $8.69M | $4.93M | (m) | $7.15M | $13.14M | (m) |
| 2012-09-30 | (m) | $8.75M | $8.62M | (m) | $7.18M | $13.41M | (m) |
| 2012-06-30 | (m) | $11.76M | $1.21M | (m) | $6.58M | $12.30M | (m) |
| 2012-03-31 | (m) | $11.51M | $1.36M | (m) | $7.60M | $10.41M | (m) |
| 2011-12-31 | (m) | $10.94M | $751.11K | (m) | $7.08M | $8.48M | (m) |
| 2011-09-30 | (m) | $7.54M | $1.81M | (m) | $6.43M | $7.71M | (m) |
| 2011-06-30 | (m) | $6.49M | $1.40M | (m) | $5.49M | $6.42M | (m) |
| 2011-03-31 | (m) | (m) | $375.41K | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $14.18M | $327.48K | (m) | $3.52M | $5.44M | (m) |
| 2010-09-30 | (m) | (m) | $571.84K | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.13M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $54.16K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |